
Inhibikase Therapeutics IKT
€ 1.79
0.5%
Inhibikase Therapeutics Kurshistorie | IKT
Kurshistorie Jährlich Inhibikase Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.63 | 1.63 | 2.3 | 0.77 | 1.06 | 6.7 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.7 | 0.77 | 2.35 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
CEL-SCI Corporation
CVM
|
2.48 | $ 2.42 | 4.76 % | $ 19.4 M | ||
|
Cytokinetics, Incorporated
CYTK
|
62.8 | $ 62.7 | 0.2 % | $ 7.53 M | ||
|
Daré Bioscience
DARE
|
1.51 | $ 0.84 | 0.04 % | $ 9.39 M | ||
|
DBV Technologies S.A.
DBVT
|
20.2 | $ 10.44 | 0.47 % | $ 1.46 B | ||
|
DiaMedica Therapeutics
DMAC
|
6.64 | $ 8.42 | 2.31 % | $ 396 M | ||
|
Denali Therapeutics
DNLI
|
14 | $ 19.91 | 0.41 % | $ 3.44 B | ||
|
Precision BioSciences
DTIL
|
5.04 | $ 6.31 | 0.16 % | $ 80.9 M | ||
|
Dyadic International
DYAI
|
0.87 | $ 0.45 | 0.31 % | $ 16.3 M | ||
|
Editas Medicine
EDIT
|
2.32 | $ 2.79 | 6.49 % | $ 248 M | ||
|
Edesa Biotech
EDSA
|
1.99 | $ 3.91 | 1.3 % | $ 22.2 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
0.96 | $ 0.36 | 0.36 % | $ 16.5 M | ||
|
Enanta Pharmaceuticals
ENTA
|
12.1 | $ 12.6 | 0.93 % | $ 269 K | ||
|
Entera Bio Ltd.
ENTX
|
1.94 | $ 2.62 | 0.69 % | $ 121 M | ||
|
Equillium
EQ
|
2.06 | $ 1.45 | 2.84 % | $ 83.1 M | ||
|
Eton Pharmaceuticals
ETON
|
20.8 | $ 55.62 | 0.47 % | $ 1.5 B | ||
|
Evogene Ltd.
EVGN
|
0.81 | $ 0.4 | 3.54 % | $ 3.15 M | ||
|
Exelixis
EXEL
|
43.1 | $ 58.85 | 0.79 % | $ 16 B | ||
|
EyePoint Pharmaceuticals
EYPT
|
15.7 | $ 3.15 | 0.62 % | $ 231 K | ||
|
Fate Therapeutics
FATE
|
1.57 | $ 2.43 | 4.74 % | $ 289 M | ||
|
Fortress Biotech
FBIO
|
2.79 | $ 2.09 | 2.96 % | $ 58.3 M | ||
|
Fennec Pharmaceuticals
FENC
|
5.91 | $ 10.62 | 4.12 % | $ 303 M | ||
|
Fulcrum Therapeutics
FULC
|
8.51 | $ 3.71 | 0.54 % | $ 235 M | ||
|
Merus N.V.
MRUS
|
46.4 | - | - | $ 5.78 B | ||
|
Galectin Therapeutics
GALT
|
2.79 | $ 3.73 | 3.72 % | $ 238 M | ||
|
Geron Corporation
GERN
|
1.59 | $ 1.21 | 0.83 % | $ 807 M | ||
|
Gilead Sciences
GILD
|
147 | $ 144.63 | 0.85 % | $ 180 B | ||
|
Greenwich LifeSciences
GLSI
|
28.5 | $ 16.91 | 0.77 % | $ 229 M | ||
|
Genmab A/S
GMAB
|
21.8 | $ 38.48 | 10.73 % | $ 2.49 B | ||
|
Genprex
GNPX
|
1.77 | $ 2.72 | 3.42 % | $ 2.54 M | ||
|
Gossamer Bio
GOSS
|
0.47 | $ 10.65 | 0.37 % | $ 2.43 B | ||
|
GeoVax Labs
GOVX
|
1.28 | $ 0.32 | 1.31 % | $ 307 K | ||
|
Grifols, S.A.
GRFS
|
6.65 | $ 7.41 | 1.37 % | $ 5.04 B | ||
|
GlaxoSmithKline plc
GSK
|
53.4 | $ 46.55 | 0.93 % | $ 189 B | ||
|
GT Biopharma
GTBP
|
0.47 | $ 6.16 | 0.98 % | $ 34 M | ||
|
Halozyme Therapeutics
HALO
|
80.6 | $ 108.31 | 2.73 % | $ 13 B | ||
|
Hutchison China MediTech Limited
HCM
|
14 | $ 14.31 | 0.77 % | $ 12.3 B | ||
|
Harmony Biosciences Holdings
HRMY
|
28 | $ 39.92 | 0.71 % | $ 2.3 B | ||
|
Heron Therapeutics
HRTX
|
1.19 | $ 0.37 | 6.44 % | $ 61.7 M | ||
|
iBio
IBIO
|
1.36 | $ 1.12 | 0.89 % | $ 117 M | ||
|
ImmuCell Corporation
ICCC
|
6.43 | $ 9.75 | 1.56 % | $ 88 M | ||
|
IDEAYA Biosciences
IDYA
|
30.8 | $ 38.06 | 1.87 % | $ 3.37 B | ||
|
InflaRx N.V.
IFRX
|
0.94 | $ 1.68 | 0.58 % | $ 113 M | ||
|
Immutep Limited
IMMP
|
2.04 | $ 4.27 | 0.46 % | $ 6.22 B | ||
|
Immunome
IMNM
|
21.6 | $ 21.17 | 1.29 % | $ 1.85 B | ||
|
Immuron Limited
IMRN
|
1 | $ 1.07 | 0.46 % | $ 247 M | ||
|
Immatics N.V.
IMTX
|
6.01 | $ 7.73 | 1.84 % | $ 946 M | ||
|
Immunic
IMUX
|
0.93 | $ 8.07 | 1.38 % | $ 1.26 B | ||
|
Immunovant
IMVT
|
35.6 | $ 33.25 | 0.18 % | $ 6.07 B | ||
|
Innate Pharma S.A.
IPHA
|
1.41 | $ 1.58 | 1.28 % | $ 142 M | ||
|
Incyte Corporation
INCY
|
99.7 | $ 114.13 | 0.06 % | $ 22.3 B |